Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty-testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmeceuticals, agriculture, and food & beverage industries, is reporting company financial results for the third quarter ended Sept. 30, 2023. The company also released a business update and limited … Continue reading InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2023 Financial Report, Business Update